All stocks ยท ADESHWAR
AM

Adeshwar Meditex Limited

ADESHWAR BSE Medical Instruments & Supplies Healthcare

Adeshwar Meditex Limited manufactures and exports sterile surgical wound dressing products and medical disposables in India and internationally. It offers sterile wound dressings under PETRONET, PARAHEAL, BACTIGAUZE PLUโ€ฆ

ISIN INE0H8J01015
Listed โ€”
Quarters tracked โ€”
Filings 10 docs

About

Adeshwar Meditex Limited manufactures and exports sterile surgical wound dressing products and medical disposables in India and internationally. It offers sterile wound dressings under PETRONET, PARAHEAL, BACTIGAUZE PLUS, NITROHEAL, PIVIDINE POVITULLE, POVIZOLE, FRAMITULLE, FUSITULLE, CALGINATE-AG SILVINET, HYDRASOOTHE, POLYBANE, and POLYBANE-N brands; combine dressings, including eye pads under the COMBIDRESS and COMBIPAD brands; and gauze dressing and cotton products, such as cotton stockinette, kneecaps, cast paddings under the ORTHOWRAP brand, rolled cotton bandages, absorbent cotton wool, abdominal pads, gauze swabs, and triangular bandages. It also provides plasters comprising elastic adhesive bandages under the A + M PLAST brand, cohesive bandages under the GLUBAN brand, adhesive tapes under the M Tape brand, microporous tapes under the AMPORE brand, synthetic casts, plaster of paris bandages under the A + MEDISET brand, capsicum belladonna perforated plasters, and cotton crepe bandages under the A + M CREPE brand; antiseptics/disinfectants under the BIODEX-C, BIO CLEAN, VILON-N, Pividine, Pividine-S, BENZ VETOL, Pividine-C, and BID QUAT brands; examination gloves and medical kits, surgical blades and blood lancets. In addition, it offers medical bandages including elastic, adhesive and non-adhesive tapes, such as medicated and non-medicated, military dressings, medicated and non-medicated, orthopedic bandages, soft products and equipment, sanitary napkins, infusion sets and allied products, antiseptic solutions, disinfectants, hand sanitizers, ointments, medicated and non-medicated, rectified spirit, extra neutral ethyl alcohol, and alcohol based products, sterile home based newborn and other kits, face masks, caps, gowns, face shield, PPE kits, HIV kits, all hospital protective wears and disposables, laboratory reagents, and testing kits. It serves hospitals, medical centers, households, and schools; and automobile and defense industries. The company was founded in 1951 and is based in Mumbai, India.

Quarterly Results

No quarterly results synced yet for this stock.

Data is backfilled from screener.in โ€” check back soon.

Profit & Loss

Annual ยท Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Sales 56.1083.7179.8582.3664.7665.9756.1252.9258.60
Expenses 53.3379.2974.6677.1461.3961.2250.6447.4452.96
Operating Profit 2.774.425.195.223.374.755.485.485.64
OPM % 4.945.286.506.345.207.209.7610.369.62
Other Income 0.100.260.130.310.230.130.280.250.10
Interest 0.611.391.932.092.032.192.522.231.78
Depreciation 0.430.500.600.530.380.350.340.350.36
Profit before tax 1.832.792.792.911.192.342.903.153.60
Tax % 31.1526.1627.9628.5233.6128.6327.2428.2529.72
Net Profit 1.262.072.012.070.791.682.122.262.54
EPS in Rs 0.871.431.391.430.551.604.034.545.10
Dividend Payout % 0.000.000.000.000.000.000.000.000.00

Balance Sheet

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Equity Capital 14.4314.4314.4314.4314.4310.535.274.984.98
Reserves 23.8522.5320.4818.4816.5210.0513.6410.818.55
Borrowings 6.0012.4513.8916.4318.9922.4521.3219.9211.58
Other Liabilities 5.9422.7915.2317.6722.6319.2714.575.797.33
Total Liabilities 50.2272.2064.0367.0172.5762.3054.8041.5032.44
Fixed Assets 2.612.953.533.703.032.242.282.442.36
CWIP 0.000.000.000.000.000.000.000.000.00
Investments 0.000.000.100.100.100.080.080.040.02
Other Assets 47.6169.2560.4063.2169.4459.9852.4439.0230.06
Total Assets 50.2272.2064.0367.0172.5762.3054.8041.5032.44

Cash Flows

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Cash from Operating Activity 4.973.803.845.77-2.443.15-0.99
Cash from Investing Activity 0.100.51-0.22-1.16-1.16-0.711.58
Cash from Financing Activity -7.09-2.66-4.36-4.634.44-3.11-0.07
Net Cash Flow -2.021.65-0.75-0.020.85-0.660.53
Free Cash Flow 4.893.863.414.57-3.612.83-1.17
CFO/OP % 198.00105.0090.00129.00-56.0081.00-3.00

Ratios

Annual ยท Days / % โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Debtor Days 135.46152.52115.51123.78183.06150.82181.26134.63108.69
Inventory Days 159.17126.64138.71127.72168.24174.35119.36112.5164.44
Days Payable 37.50104.0375.9788.18138.51119.86104.7038.7643.11
Cash Conversion Cycle 257.13175.13178.25163.33212.79205.31195.93208.39130.02
Working Capital Days 225.25135.78129.04116.60147.05111.49124.03108.29129.43
ROCE % 5.218.279.6210.076.9311.2214.2717.69โ€”

Shareholding Pattern

% holding โ€” latest first
Holder Mar 2026 Sep 2025 Mar 2025 Sep 2024 Mar 2024 Sep 2023 Mar 2023 Sep 2022 Mar 2022 Sep 2021 Jun 2021
Promoters 57.68 57.55 57.55 57.55 42.65 42.65 42.65 42.65 42.65 42.65 58.45
Public 42.33 42.44 42.44 42.45 57.35 57.33 57.36 57.35 57.35 57.35 41.55
No. of Shareholders 192 187 188 182 179 181 164 171 188 219 10

Corporate Actions

No corporate actions recorded.

Announcements

5 filings